| 000 | 01763 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516205330.0 | ||
| 264 | 0 | _c20140624 | |
| 008 | 201406s 0 0 eng d | ||
| 022 | _a1872-7786 | ||
| 024 | 7 |
_a10.1016/j.cbi.2014.03.013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDai, Jie | |
| 245 | 0 | 0 |
_aInvolvement of catalase in the protective benefits of metformin in mice with oxidative liver injury. _h[electronic resource] |
| 260 |
_bChemico-biological interactions _cJun 2014 |
||
| 300 |
_a34-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCarbon Tetrachloride Poisoning |
| 650 | 0 | 4 |
_aCatalase _xmetabolism |
| 650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xdrug therapy |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 |
_aGlutathione Peroxidase _xgenetics |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aImmunoblotting |
| 650 | 0 | 4 |
_aInterleukin-6 _xgenetics |
| 650 | 0 | 4 |
_aMetformin _xtherapeutic use |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aOxidative Stress |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aProtein Conformation |
| 650 | 0 | 4 |
_aSuperoxide Dismutase _xmetabolism |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xgenetics |
| 700 | 1 | _aLiu, Mingwei | |
| 700 | 1 | _aAi, Qing | |
| 700 | 1 | _aLin, Ling | |
| 700 | 1 | _aWu, Kunwei | |
| 700 | 1 | _aDeng, Xinyu | |
| 700 | 1 | _aJing, Yuping | |
| 700 | 1 | _aJia, Mengying | |
| 700 | 1 | _aWan, Jingyuan | |
| 700 | 1 | _aZhang, Li | |
| 773 | 0 |
_tChemico-biological interactions _gvol. 216 _gp. 34-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cbi.2014.03.013 _zAvailable from publisher's website |
| 999 |
_c23723140 _d23723140 |
||